BIOJECT MEDICAL TECHNOLOGIES INC 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jan 24, 2008
Insider Transaction Report
Form 4
Makar Ralph
CEO/President
Transactions
- Award
Series F Convertible Preferred Stock
2008-01-22$0.75/sh+67,600$50,700→ 324,267 totalExercise: $0.75From: 2008-01-22→ BJCT Common Stock (67,600 underlying)
Footnotes (3)
- [F1]Paid by the cancellation of the outstanding principal and accrued interest of the 8% Convertible Promissory Note issued November 19, 2007.
- [F2]No expiration date.
- [F3]Includes Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000, Restricted Stock Unit 100,000.